← 治験一覧に戻る
エルゴチオネイン含有サプリメントの継続摂取による皮膚状態への影響
基本情報
- NCT ID
- NCT06886061
- ステータス
- 完了
- 試験のフェーズ
- 該当なし
- 試験タイプ
- 介入
- 目標被験者数
- 70
- 治験依頼者名
- Shanghai EGT Synbio Group Co., Ltd.
概要
This trial employed a non-randomized, double-blind, placebo-controlled design to evaluate the effects of DR. ERGO® Capsules (each containing 30mg of ergothioneine) on the skin condition of women aged 35 to 59 after continuous daily intake for 8 weeks. The trial assessed skin condition across multiple dimensions, including brightness, color tone, melanin, erythema, gloss, elasticity, and spots, using various instruments and questionnaire surveys. Additionally, safety was monitored through daily log records and safety evaluations.
対象疾患
Skin
介入
The capsules contain Ergothioneine.(DIETARY_SUPPLEMENT)
The capsules do not contain Ergothioneine.(DIETARY_SUPPLEMENT)
依頼者（Sponsor）
Shanghai Egt Synbio Group(INDUSTRY)
実施施設 (1)
公益社団法人日本海員掖済会 大阪掖済会病院
Tokyo, Shinjukuku, Japan